glyNOcalyx 30 Tablets

glyNOcalyx — Next-Generation Cardiovascular Formula for Glycocalyx and Endothelial Health

HumanN glyNOcalyx is a next-generation cardiovascular formula specifically targeting the endothelial glycocalyx — the carbohydrate-protein mesh that coats the inner surface of every blood vessel wall and serves as the primary interface between the bloodstream and the endothelium. The glycocalyx plays a critical and largely underappreciated role in cardiovascular health: it regulates blood vessel permeability, prevents pathological platelet and white cell adhesion to vessel walls, transmits shear stress signals that stimulate nitric oxide production by endothelial cells, and provides a protective barrier against LDL infiltration into the vessel wall. Glycocalyx degradation is now recognized as an early and significant contributor to cardiovascular disease.

glyNOcalyx features four clinically studied, plant-based ingredients at clinical-strength dosages, delivered using HumanN's unique SlideTech™ Tablet Coating Technology for optimized dissolution and bioavailability. The formula represents HumanN's most advanced cardiovascular science — building beyond the established nitric oxide pathways to address the structural vascular health that underlies long-term cardiovascular function.

• Four clinically studied ingredients targeting glycocalyx structural health
• Supports healthy blood pressure and endothelial function
• SlideTech™ Tablet Coating Technology — optimized dissolution and bioavailability
• Next-generation cardiovascular support beyond standard nitric oxide formulas
• 30 tablets; non-GMO, gluten-free; third-party tested

Take as directed on label or by your healthcare provider.